Hematology NewsSome mutation testing can be useful at CLL diagnosisOctober 5, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsNovel options for treating hairy cell leukemiaOctober 2, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaB Cell Lymphoma
Hematology NewsReal-world clues for optimal sequencing of CLL novel agentsSeptember 25, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves new drug for CLL/SLL and follicular lymphomaSeptember 25, 2018CLLIndolent LymphomaLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsFDA approves new hairy cell leukemia drugSeptember 13, 2018CLLLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsVenetoclax label now includes MRD dataSeptember 12, 2018CLLAggressive LymphomasLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsRESONATE-2 update: First-line ibrutinib has sustained efficacy in older CLL patientsSeptember 6, 2018CLLAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsCombo treatment yields MRD-negative remissions in CLLAugust 23, 2018CLLLeukemia, Myelodysplasia, TransplantationAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsCaution urged over real-world bleeding risk with ibrutinibAugust 14, 2018CLLAggressive LymphomasPatient & Survivor CareB Cell Lymphoma
Hematology NewsNew chronic lymphocytic leukemia guidelines from the UKAugust 8, 2018CLLLeukemia, Myelodysplasia, TransplantationIndolent Lymphoma
Hematology NewsIsavuconazole resolved invasive fungal disease in patients on ibrutinibJuly 29, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCLL
Hematology NewsIbrutinib stacks up well on safety in pooled analysisJuly 20, 2018CLLLeukemia, Myelodysplasia, TransplantationB Cell Lymphoma
Hematology NewsIbrutinib/venetoclax shows early promise in relapsed CLLJuly 11, 2018CLLAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsRapid venetoclax dose escalation aids relapsed CLLJuly 5, 2018Aggressive LymphomasCLLLymphoma & Plasma Cell Disorders
Hematology NewsIs CLL chemoimmunotherapy dead? Not yetJune 20, 2018CLLLymphoma & Plasma Cell DisordersIndolent Lymphoma
